– Pivotal Phase III IMbrave050 study investigating Tecentriq plus Avastin in people with early-stage hepatocellular carcinoma (HCC) at high risk of recurrence following surgery met primary endpoint of ...
A new analysis raises fresh questions about the risks of the blockbuster cancer drug Avastin, suggesting the chance of dying from side effects linked to it is higher than the risk for patients on ...
Common side effects of Tecentriq when used alone include cough, decreased appetite, fatigue or weakness, nausea, and shortness of breath. Tecentriq can cause serious immune system reactions that may ...
Effect of oxymatrine on the side population and expression of β-catenin in MCF-7 breast cancer cells. Background: This study evaluates patients for increased pulmonary arterial pressures when treated ...
A new study has linked Genentech's cancer drug Avastin to a higher rate of deadly side effects, the Wall Street Journal reports. The analysis, conducted by researchers at Stony Brook University ...
Avastin-Tarceva combination improved progression-free survival in advanced gallbladder cancer and cholangiocarcinoma compared to active surveillance. The study reported a median PFS of 5.3 months for ...
Fatal side effects were 1.5 times more frequent among patients on Avastin plus chemotherapy than among those getting chemotherapy alone.The highest risk was seen in patients with prostate and lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback